Differential effects of agents acting at various sites of the NMDA receptor complex in a place preference conditionig model

European Journal of Pharmacology

Volumn 317, Issue 2-3, 1996, Pages 191-196

  Papp, Mariusz ^a   Moryl, Elzbieta ^a   Maccecchini, Maria Luisa ^b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b Symphony Pharmaceuticals   (United States)

Author keywords

ACPC (1 aminocyclopropanecarboxylic acid); CGP 37849; CGP 40116; Conditioned preference; Glycine site; MK 801; NMDA receptor; Reward

Indexed keywords

1 AMINOCYCLOPROPANECARBOXYLIC ACID; 2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ABUSE; ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT;

2-AMINO-5-PHOSPHONOVALERATE; AMINO ACIDS; AMINO ACIDS, CYCLIC; ANIMALS; BINDING, COMPETITIVE; CONDITIONING, OPERANT; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; RATS; RATS, WISTAR; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0030593927     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00747-9     Document Type: Article

References (53)

1. Anthony, E.W. and M.E. Nevins, 1993, Anxiolytic-like effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test, Eur. J. Pharmacol. 250, 317.
2. Beardsley, P.M., B.A. Hayes and R.L. Balster, 1990, The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys, J. Pharmacol. Exp. Ther. 252, 953.
3. Bespalov, A., M. Dumpis, L. Piotrovsky and E. Zvartau, 1994, Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine, Eur. J. Pharmacol. 264, 233.
4. Bubser, M., U. Keseberg, P.K. Notz and W.J. Schmidt, 1992, Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats, Eur. J. Pharmacol. 229, 75.
5. Carr, G.F., H.C. Fibiger and A.G. Phillips, 1989, Conditioned place preference as a measure of drug reward, in: The Neuropharmacological Basis of Reward, eds. J.M. Liebman and S.J. Cooper (Clarendon, Oxford) p. 264.
6. Carter, A.J., 1992, Glycine antagonist: regulation of the NMDA receptor channel complex by the strychnine-insensitive glycine site, Drugs Future 17, 595.
7. Carter, A.J., 1995, Antagonists of the NMDA receptor-channel complex and motor coordination, Life Sci. 57, 917.
8. Cherkofsky, S.C., 1995, 1-Aminocyclopropanecarboxylic acid: mouse to man interspecies pharmacokinetic comparisons and allometric relationships, J. Pharmaceut. Sci. 84, 1231.
9. Collingridge, G.L. and W. Singer, 1990, Excitatory amino acid receptors and synaptic plasticity, TIPS 11, 290.
10. 1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze, Eur. J. Pharmacol. 169, 1.
11. Dunn, R., D. Flanagan, L. Martin, L. Kerman, A. Woods, F. Camacho, C. Wilmot, M. Cornfeldt, M. Effland, P. Wood and R. Carbide, 1992, Stereoselective R-(+) enantiomer of HAA-966 displays anxiolytic effects in rodents, Eur. J. Pharmacol. 314, 207.
12. Faden, A. and S. Salzman, 1992, Pharmacological strategies in CNS trauma, Trends Pharmacol. Sci. 13, 29.
13. Faiman, C.P., E. Viu, P. Skolnick and R. Trullas, 1994, Different effects of compounds that act at strychnine-insensitive glycine receptors in a punishment procedure, J. Pharmacol. Exp. Ther. 270, 528.
14. Fossom, L.H., D.K.J.E. Von Lubitz, R.C.S. Lin and P. Skolnick, 1995, Neuroprotective actions of 1-aminocyclopropanecarboxylic acid (ACPC): a partial agonist at strychnine-insensitive glycine sites, Neurol. Res. 17, 265.
15. French, E.D. and A. Ceci, 1990, Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons, Neurosci. Lett. 119, 159.
16. French, E.D., J. Ferkany, M. Abreu and S. Levenson, 1991, Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine, Neuropharmacology 30, 1039.
17. Gandolfi, O., R. Rimondini and R. Dall'Olio, 1994, D-Cycloserine decreases both D1 and D2 dopamine receptors number and their function in rat brain, Pharmacol. Biochem. Behav. 48, 351.
18. Goudie, A.J., 1991, Animal models of drug abuse and dependence, in: Behavioural Models in Psychopharmacology, ed. P. Willner (Cambridge University Press, Cambridge) p. 453.
19. Gean, D.W. and A. Shinnick-Gallaher, 1988, Epileptiform activity induced by magnesium-free solution in slices of rat amygdala: antagonism by N-methyl-D-aspartate receptor antagonists, Neuropharmacology 27, 557.
20. Grotta, J., W. Clark, B. Coull, L.C. Pettigrew, B. Mackay, L.B. Goldstein, I. Meissner, D. Murphy and L. Laure, 1995, Safety and tolerability of the glutamate antagonist CGS 19755 (selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial, Stroke 26, 602.
21. Herberg, L.J. and C.I. Rose, 1989, The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward, Psychopharmacology 99, 87.
22. Hoffman, D.C., 1994, The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats, Pharmacol. Biochem. Behav. 47, 907.
23. Kehne, J.H., T.C. McCloskey, B.M. Baron, E.M. Chi, B.L. Harrison, J.P. Whitten and M.G. Palfreyman, 1991, NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalization, Eur. J. Pharmacol. 193, 283.
24. Kehne, J.H., B.M. Baron, B.L. Harrison, T.C. McCloskey, M.G. Palfreyman, M. Poirot, F.G. Salituro, B.W. Siegel, A.L. Slone, P.L.M. Van Giersbergen and J.P. Whitten, 1995, MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles, Eur. J. Pharmacol. 284, 109.
25. Kleckner, N.W. and R. Dingledine, 1988, Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes, Science 241, 835.
26. Koek, W. and J.H. Woods, 1988, N-methyl-D-aspartate antagonism and phencyclidine-like activity: behavioral studies, in: Frontiers in Excitatory Amino Acid Research, eds. E.A. Cavalheiro, J. Lehmann and L. Turski (Alan R. Liss, New York, NY) p. 535.
27. Koek, W., J.H. Woods and G.D. Winger, 1988, MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys, J. Pharmacol. Exp. Ther. 245, 969.
28. Layer, R.T., L.R. Bland and P. Skolnick, 1993, MK-801, but not drugs acting at strychnine-insensitive glycine receptors, attenuate methamphetamine nigrostriatal toxicity, Brain Res. 625, 38.
29. Löscher, W., R. Annies and D. Hönack, 1993, Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioral effects in rats. Eur. J. Pharmacol. 242, 263.
30. Maj, J., Z. Rogoz, G. Skuza and H. Sowinska, 1992, The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test, Pol. J. Pharmacol. 44, 337.
31. Marvizon, J.-C.G., A.H. Lewin and P. Skolnick, 1989, 1-aminocyclopropane carboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex, J. Neurochem. 52, 992.
32. Meldrum, B. and J. Garthwaite, 1990, Excitatory amino acid neurotoxicity and neurodegenerative disease, Trends Pharmacol. Sci. 11, 379.
33. Nowak, G., R. Trullas, R.T. Layer, P. Skolnick and I.A. Paul, 1993, Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid, J. Pharmacol. Exp. Ther. 265, 1380.
34. Olney, J.W., J. Labruyere and M.T. Price, 1990, Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs, Science 244, 1360.
35. Papp, M. and E. Moryl, 1994a, Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression, Eur. J. Pharmacol. 263, 1.
36. Papp, M. and E. Moryl, 1994b, Attenuation by haloperidol of the place preference conditioning induced by non-competitive and competitive NMDA antagonists, Behav. Pharmacol. 5 (Suppl. 1), 108.
37. Patel, S., A.G. Chapman, J.L. Graham, B.S. Meldrum and P. Frey, 1990, Anticonvulsant activity of the NMDA antagonists, D-CPP and D-CPPene, in a rodent and primate model of reflex epilepsy, Epilepsy Res. 7, 3.
38. Paul, I.A., R.T. Layer, P. Skolnick and G. Nowak, 1993, Adaptation of the NMDA receptor in the rat cortex following chronic electroconvulsive shock and imipramine, Eur. J. Pharmacol. 247, 305.
39. Paul, I.A., G. Nowak, R.T. Layer, P. Popik and P. Skolnick, 1994, Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments, J. Pharmacol. Exp. Ther. 269, 95.
40. Rundfeldt, C., P. Wlaz and W. Löscher, 1994, Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy, Brain Res. 653, 125.
41. Rupniak, N.M.J., S. Boyce, S. Tye, G. Cook and S. Iversen, 1993, Anxiolytic-like effects of MK-801 accompanied by sedation and ataxia in primates, Pharmacol. Biochem. Behav. 44, 153.
42. Schechter, D.M. and D.J. Calcagnetti, 1993, Trends in place preference conditioning with a cross-indexed bibliography, 1957-1991, Neurosci. Biobehav. Rev. 17, 21.
43. Sveinbjornsdottir, S., J.W.A.S. Sander, D. Upton, P.J. Thompson, P.N. Patsalos, D. Hirt, M. Emre, D. Lowe and J.S. Duncan, 1993, The excitatory amino acid antagonist D-CPP-ene (Sdz Eaa-494) in patients with epilepsy, Epilepsy Res. 16, 165.
44. Szatkowski, M. and D. Attwell, 1994, Triggering and executing of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms, Trends Neurosci. 17, 359.
45. Trullas, R., B. Jackson and P. Skolnick, 1989, Anxiolytic properties of 1-aminocyclopropanecarboxylic acid, a ligand at strychnine-insensitive glycine receptors, Pharmacol. Biochem. Behav. 34, 313.
46. Trullas, R., T. Folio, A. Young, R. Miller, K. Boje and P. Skolnick, 1991, 1-Aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models, Eur. J. Pharmacol. 203, 379.
47. Trullas, R. and P. Skolnick, 1990, Functional antagonists at the NMDA receptor complex exhibit antidepressant actions, Eur. J. Pharmacol. 185, 1.
48. Turski, W.A., E. Urbanska, M. Dziki, J. Parada-Turska and C. Ikonomidu, 1990, Excitatory aminoacid antagonists protect mice against seizures induced by bicuculine, Brain Res. 514, 131.
49. Tzschentke, T.M. and W.J. Schmidt, 1995, N-Methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats, Neurosci. Lett. 193, 37.
50. Von Lubitz, D.K.J.E., R.C.S. Lin, R.J. McKenzie, T.M. Devlin, T.R. McCabe and P. Skolnick, 1992, A novel treatment of global ischaemia with a glycine partial agonist, Eur. J. Pharmacol. 219, 153.
51. Wedzony, K., K. Golembiowska and M. Zazula, 1994, Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect of the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 555.
52. Wedzony, K., A. Czyrak, M. Mackowiak and K. Fijal, 1996, The impact of a competitive and non-competitive NMDA receptor antagonists on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra, Naunyn-Schmiedeberg's Arch. Pharmacol. (in press).
53. Willetts, J., R.L. Balster and J.D. Leander, 1990, The behavioral pharmacology of NMDA receptor antagonists, Trends Pharmacol. Sci. 11, 423.